South San Francisco, CA · Founded 2018 · Privately Held (backing)
Developer of an artificial intelligence-based drug discovery model designed for genetically defined neurological and immunological diseases. Neuron23 is based in South San Francisco, CA and was founded in 2018. Its last reported valuation was $272 million in Jun 2025. It has raised $310 million.
Last reported valuation
$271.5M
Oct 2026
Priced at
—
Total raised
$310.0M
Last round
—
Team — not yet on record
No current team members for Neuron23 are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Neuron23 with a free account
·The complete investor list: 14 names
·Watch Neuron23: the Monday email on marks, rounds and moves
